.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
US Department of Justice
Baxter
McKinsey
Novartis
Cantor Fitzgerald
Covington
Fish and Richardson
AstraZeneca
Chinese Patent Office

Generated: January 19, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to United Kingdom Patent: 0229893.3

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
NovartisTASIGNAnilotinib hydrochloride monohydrateCAPSULE;ORAL022068-001Oct 29, 2007RXYesYes➤ Subscribe➤ SubscribeYYA METHOD FOR THE TREATMENT OF LEUKEMIAS
NovartisTASIGNAnilotinib hydrochloride monohydrateCAPSULE;ORAL022068-002Jun 17, 2010RXYesNo➤ Subscribe➤ SubscribeYYA METHOD FOR THE TREATMENT OF LEUKEMIAS
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist